BrainsWay

BrainsWay is an international medical device company founded in 2003 and headquartered in Jerusalem, Israel, specializing as a global leader in advanced noninvasive neurostimulation treatments for mental health disorders using its proprietary Deep Transcranial Magnetic Stimulation platform technology. The company utilizes Deep Transcranial Magnetic... Stimulation with unique patented technology developed in collaboration with the National Institute of Health. BrainsWay is the first and only TMS company to obtain three FDA-cleared indications backed by pivotal studies, with current indications including major depressive disorder, including reduction of anxiety symptoms commonly referred to as anxious depression, obsessive-compulsive disorder, and smoking addiction. The Deep TMS platform technology is also used for treatment of bipolar disorders, post traumatic stress disorders, schizophrenia, chronic pain, and other neurological and psychiatric conditions. The company serves doctors, hospitals, and medical centers in the field of psychiatry, operating in the United States, East Asia, and internationally. BrainsWay is dual-listed on the NASDAQ and Tel Aviv Stock Exchange.Read More